Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Ethyl Acetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL18498857 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL16267234 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL192603 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL508898 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL525361 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL5036694 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL9731700 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL18237169 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL1163855 | 1.00 | ALDH1A1 (0.93) | — | |
| Ethyl Acetate SCHEMBL1150646 | 1.00 | ALDH1A1 (0.93) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2565 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209411-A | Synthesis method of indolal and derivative thereof | 苏州翔实医药发展有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-111115600-B | Method for synthesizing hydroxyapatite Dan Aotu nano-rod with assistance of ethyl acetate | 天津工业大学 | 2022-12-13 | — | — | CN | claimed |
| CN-113135964-B | Metal iridium-ferrocene Schiff base complex and preparation method thereof | 曲阜师范大学 | 2022-08-12 | — | — | CN | claimed |
| CN-113135964-A | Metal iridium-ferrocene Schiff base complex and preparation method thereof | 曲阜师范大学 | 2021-07-20 | — | — | CN | claimed |
| CN-108276360-B | Synthesis method of novel fluorescent molecular probe PP for detecting lead ions | 青海大学 | 2021-07-06 | — | — | CN | claimed |
| CN-111943959-A | Synthetic method of JAK inhibitor | 上海再极医药科技有限公司 | 2020-11-17 | — | — | CN | claimed |
| CN-111115600-A | Method for synthesizing hydroxyapatite concave-convex nano rod with assistance of ethyl acetate | 天津工业大学 | 2020-05-08 | — | — | CN | claimed |
| CN-106117177-B | Optical activity ganoderma lucidum phenol intermediate and preparation method thereof | 中国科学院昆明植物研究所 | 2018-07-27 | — | — | CN | claimed |
| CN-106117177-A | Optical activity Ganoderma phenol intermediate and preparation method thereof | 中国科学院昆明植物研究所 | 2016-11-16 | — | — | CN | claimed |
| CN-104650059-A | Thiazolone oxime ether derivatives, and preparation method and use thereof | UNIV NANKAI | 2015-05-27 | — | — | CN | claimed |
| US-12042495-B2 | MAP4K1 inhibitors | BLUEPRINT MEDICINES CORPORATION (US) | 2024-07-23 | — | — | US | disclosed |
| WO-2024149340-A1 | INDOLONE DERIVATIVE HAVING IRAK4 INHIBITORY ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳众格生物科技有限公司 | 2024-07-18 | — | — | WO | disclosed |
| US-20240238424-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. | 2024-07-18 | — | — | US | disclosed |
| WO-2024149378-A1 | QUINOLINONE COMPOUND AND NAPHTHYRIDINONE COMPOUND AND USE THEREOF | 上海超阳药业有限公司 | 2024-07-18 | — | — | WO | disclosed |
| WO-2024149261-A1 | INHIBITOR OF COMPLEMENT FACTOR B | 南京正大天晴制药有限公司 | 2024-07-18 | — | — | WO | disclosed |
| US-5130241-A | CLAVAM DERIVATIVES AND ITS ENZYMATIC PREPARATION | BEECHAM GROUP PLC (GB) | 1992-07-14 | — | — | US | disclosed |
| US-4795809-A | CLAVULANIC ACID INTERMEDIATE | BEECHAM GROUP PLC (GB) | 1989-01-03 | — | — | US | disclosed |
| EP-0213914-A2 | Clavam derivatives, preparation and intermediates therefor | BEECHAM GROUP PLC (GB) | 1987-03-11 | — | — | EP | disclosed |
| US-4059584-A | ANTIINFLAMMATORY | PFIZER (US) | 1977-11-22 | — | — | US | disclosed |
| US-4002623-A | Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines | PFIZER INC. (US) | 1977-01-11 | — | — | US | disclosed |